MX9302833A - Piridinas substituidas, proceso para su preparacion y composicion farmaceutica que las comprende. - Google Patents
Piridinas substituidas, proceso para su preparacion y composicion farmaceutica que las comprende.Info
- Publication number
- MX9302833A MX9302833A MX9302833A MX9302833A MX9302833A MX 9302833 A MX9302833 A MX 9302833A MX 9302833 A MX9302833 A MX 9302833A MX 9302833 A MX9302833 A MX 9302833A MX 9302833 A MX9302833 A MX 9302833A
- Authority
- MX
- Mexico
- Prior art keywords
- pct
- piridines
- substituted
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Cosmetics (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929210489A GB9210489D0 (en) | 1992-05-15 | 1992-05-15 | Heterocyclic compounds,their preparation and pharmaceutical use |
| GB929223738A GB9223738D0 (en) | 1992-11-12 | 1992-11-12 | Heterocyclic compounds,their preparation and pharmaceutical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9302833A true MX9302833A (es) | 1993-11-01 |
Family
ID=26300892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9302833A MX9302833A (es) | 1992-05-15 | 1993-05-14 | Piridinas substituidas, proceso para su preparacion y composicion farmaceutica que las comprende. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5595995A (enExample) |
| EP (1) | EP0640072B1 (enExample) |
| JP (1) | JPH07506588A (enExample) |
| KR (1) | KR100235976B1 (enExample) |
| AT (1) | ATE195728T1 (enExample) |
| AU (1) | AU673837B2 (enExample) |
| CA (1) | CA2134563A1 (enExample) |
| DE (1) | DE69329281T2 (enExample) |
| ES (1) | ES2149817T3 (enExample) |
| IL (1) | IL105666A (enExample) |
| MX (1) | MX9302833A (enExample) |
| NO (1) | NO302069B1 (enExample) |
| NZ (1) | NZ252717A (enExample) |
| TW (1) | TW223631B (enExample) |
| WO (1) | WO1993023375A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69705772T2 (de) * | 1996-05-28 | 2001-11-15 | Pfizer Inc., New York | Adamantyl substituierte Oxindole als pharmazeutische Wirkstoffe |
| US7795468B2 (en) * | 2001-01-19 | 2010-09-14 | Chevron U.S.A. Inc. | Functionalized higher diamondoids |
| US6864264B1 (en) * | 2002-08-20 | 2005-03-08 | Gloria L. Anderson | 1-adamantyl chalcones for the treatment of proliferative disorders |
| JP2006160605A (ja) * | 2003-07-09 | 2006-06-22 | Nippon Kayaku Co Ltd | 新規酵素阻害剤 |
| JP2008007404A (ja) * | 2004-10-08 | 2008-01-17 | Nippon Kayaku Co Ltd | 新規ピリジン誘導体 |
| MX2007015863A (es) | 2005-06-17 | 2008-04-02 | Apogee Biotechnology Corp | Inhibidores de esfingosina cinasa. |
| GB0803494D0 (en) * | 2008-02-26 | 2008-04-02 | Sterix Ltd | Compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971797A (en) * | 1973-06-15 | 1976-07-27 | Merck & Co., Inc. | S,S'-bis(pyridylmethyl)-carbonodithioates |
| IL83163A (en) * | 1986-07-18 | 1991-06-10 | Erba Carlo Spa | Cycloalkyl-substituted 4-pyridyl derivatives,their preparation and pharmaceutical compositions containing them |
| DE4018260A1 (de) * | 1990-06-07 | 1991-12-12 | Basf Ag | Derivate des (beta)-picolins und diese enthaltende pflanzenschutzmittel |
-
1993
- 1993-04-29 JP JP5519965A patent/JPH07506588A/ja active Pending
- 1993-04-29 AU AU42674/93A patent/AU673837B2/en not_active Ceased
- 1993-04-29 AT AT93911885T patent/ATE195728T1/de not_active IP Right Cessation
- 1993-04-29 KR KR1019940704105A patent/KR100235976B1/ko not_active Expired - Fee Related
- 1993-04-29 US US08/335,743 patent/US5595995A/en not_active Expired - Fee Related
- 1993-04-29 WO PCT/GB1993/000890 patent/WO1993023375A1/en not_active Ceased
- 1993-04-29 EP EP93911885A patent/EP0640072B1/en not_active Expired - Lifetime
- 1993-04-29 CA CA002134563A patent/CA2134563A1/en not_active Abandoned
- 1993-04-29 ES ES93911885T patent/ES2149817T3/es not_active Expired - Lifetime
- 1993-04-29 DE DE69329281T patent/DE69329281T2/de not_active Expired - Fee Related
- 1993-04-29 NZ NZ252717A patent/NZ252717A/en unknown
- 1993-04-30 TW TW082103369A patent/TW223631B/zh active
- 1993-05-11 IL IL10566693A patent/IL105666A/en not_active IP Right Cessation
- 1993-05-14 MX MX9302833A patent/MX9302833A/es not_active IP Right Cessation
-
1994
- 1994-11-14 NO NO944332A patent/NO302069B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO944332D0 (no) | 1994-11-14 |
| NO302069B1 (no) | 1998-01-19 |
| ES2149817T3 (es) | 2000-11-16 |
| EP0640072A1 (en) | 1995-03-01 |
| IL105666A0 (en) | 1993-09-22 |
| NZ252717A (en) | 1996-05-28 |
| ATE195728T1 (de) | 2000-09-15 |
| DE69329281T2 (de) | 2001-03-15 |
| JPH07506588A (ja) | 1995-07-20 |
| IL105666A (en) | 1999-09-22 |
| US5595995A (en) | 1997-01-21 |
| KR100235976B1 (ko) | 1999-12-15 |
| CA2134563A1 (en) | 1993-11-25 |
| EP0640072B1 (en) | 2000-08-23 |
| KR950701620A (ko) | 1995-04-28 |
| DE69329281D1 (de) | 2000-09-28 |
| AU673837B2 (en) | 1996-11-28 |
| AU4267493A (en) | 1993-12-13 |
| NO944332L (no) | 1994-11-14 |
| TW223631B (enExample) | 1994-05-11 |
| WO1993023375A1 (en) | 1993-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE208772T1 (de) | Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| TR27835A (tr) | Sübstitüe edilmis azadiokzasikloalkenler. | |
| DK0696281T3 (da) | Hidtil ukendte 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazolderivater | |
| NO951318L (no) | 25-karboxylsyrederivater i vitamin D-serien, fremgangsmåte for fremstilling av disse, mellomprodukter for fremgangsmåten, farmasöytiske preparater inneholdende disse derivater og deres anvendelse ved fremstilling av medisiner | |
| PT99135A (pt) | Processo para a preparacao de derivados de piperazina | |
| DK0564350T3 (da) | 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning | |
| ATE138647T1 (de) | 23-oxa-derivate in der vitamin-d-reihe, verfahren zu ihrer herstellung, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung als arzneimittel | |
| DK0632805T3 (da) | Melaminderivater til anvendelse i behandlingen af cancer | |
| DK0649405T3 (da) | 22-en-25-oxa-derivater i D-vitaminserien, fremgangsmåde til fremstilling heraf, farmaceutiske præparater indeholdende disse derivater samt anvendelse af sådanne præparater som lægemidler. | |
| NO931905D0 (no) | 8-en-19, 11beta-broede steroider, deres fremstilling og farmasoeytiske preparater inneholdende disse | |
| ES2149817T3 (es) | Piridinas sustituidas, su preparacion y uso farmaceutico. | |
| CS180191A3 (en) | Novel derivatives of oxazole, process for their preparation and pharmaceuticals containing them | |
| PT99280A (pt) | Processo de preparacao de derivados do indolo e de composicoes farmaceuticas | |
| DK0912568T3 (da) | Imidazopyridiner | |
| IL115085A0 (en) | Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them | |
| FI962301A0 (fi) | Substituoidut aminoalkyyliaminopyridiinit | |
| ATE195311T1 (de) | Phenoxyethylamin-derivate mit hoher affinität fur den 5-ht1a-rezeptor, verfahren zu ihrer herstellung, ihre verwendung als medikamente und sie enthaltende pharmazeutische zusammensetzungen | |
| DK0424248T3 (da) | 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf | |
| YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |